Francis W. Sarena
2016
In 2016, Francis W. Sarena earned a total compensation of $4.2M as Chief Strategy Officer and Secretary at Five Prime Therapeutics, a 40% increase compared to previous year.
Compensation breakdown
| Bonus | $145,550 |
|---|---|
| Non-Equity Incentive Plan | $201,600 |
| Option Awards | $2,719,072 |
| Salary | $392,188 |
| Stock Awards | $783,880 |
| Other | $6,000 |
| Total | $4,248,290 |
Sarena received $2.7M in option awards, accounting for 64% of the total pay in 2016.
Sarena also received $145.6K in bonus, $201.6K in non-equity incentive plan, $392.2K in salary, $783.9K in stock awards and $6K in other compensation.
Rankings
In 2016, Francis W. Sarena's compensation ranked 2,039th out of 14,075 executives tracked by ExecPay. In other words, Sarena earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,039 out of 14,075 | 86th |
Division Manufacturing | 699 out of 5,489 | 87th |
Major group Chemicals And Allied Products | 201 out of 1,895 | 89th |
Industry group Drugs | 144 out of 1,538 | 91st |
Industry Pharmaceutical Preparations | 116 out of 1,176 | 90th |
Source: SEC filing on March 30, 2018.
Sarena's colleagues
We found five more compensation records of executives who worked with Francis W. Sarena at Five Prime Therapeutics in 2016.
2016
Lewis Williams
Five Prime Therapeutics
Chief Executive Officer
2016
Kevin Baker
Five Prime Therapeutics
Senior Vice President, Product Development
2016
Aron Knickerbocker
Five Prime Therapeutics
Chief Operating Officer
2016
Robert Sikorski
Five Prime Therapeutics
Chief Medical Officer
2016
Marc Belsky
Five Prime Therapeutics